Legend Biotech (LEGN) Cash from Operations (QoQ) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -142.36% |
| Sep 30, 2025 | 320.83% |
| Jun 30, 2025 | 87.43% |
| Mar 31, 2025 | -26.38% |
| Dec 31, 2024 | -8.28% |
| Sep 30, 2024 | -4,492.49% |
| Jun 30, 2024 | -110.64% |
| Mar 31, 2024 | 116.22% |
| Dec 31, 2023 | -57.19% |
| Sep 30, 2023 | 37.64% |
| Jun 30, 2023 | 29.92% |
| Mar 31, 2023 | -179.87% |
| Dec 31, 2022 | 31.02% |
| Sep 30, 2022 | -9,644.86% |
| Jun 30, 2022 | 99.06% |
| Mar 31, 2022 | 60.35% |
| Dec 31, 2021 | -345.06% |
| Sep 30, 2021 | 22.59% |
| Jun 30, 2021 | -115.06% |
| Mar 31, 2021 | 87.99% |
| Dec 31, 2020 | -246.42% |
| Sep 30, 2020 | -13.17% |
| Jun 30, 2020 | -24.21% |
| Mar 31, 2020 | 23.66% |
| Dec 31, 2019 | -400.73% |
| Sep 30, 2019 | 151.45% |